BRIEF published on 04/20/2026 at 07:35, 3 days 13 hours ago Last day for exercising Nicox warrants: June 19, 2026 Euronext Growth Deadline Share Subscription Ophthalmology BSA Nicox
BRIEF published on 04/20/2026 at 07:35, 3 days 13 hours ago Nicox Sets Deadline for June 2024 Warrants Exercise Warrants Shares Euronext Nicox Exercise Deadline
PRESS RELEASE published on 04/20/2026 at 07:30, 3 days 14 hours ago Reminder: Last Exercise Day for Nicox June 2024 Warrants is June 19, 2026 Nicox SA reminds warrant holders of the upcoming expiration date on June 19, 2026. The warrants, with ISIN code FR001400QEQ3, provide the right to subscribe to new shares at €0.275 per share Euronext Growth Paris Warrants Equity Offering Expiration Date Nicox SA
BRIEF published on 02/24/2026 at 07:35, 1 month 27 days ago Nicox Reveals Positive Phase 3 Results for NCX 470 at AGS Meeting Glaucoma Phase 3 Study NCX 470 Intraocular Pressure Therapeutic Profile
PRESS RELEASE published on 02/24/2026 at 07:30, 1 month 27 days ago Nicox Highlights Positive NCX 470 Phase 3 Data Confirming Therapeutic Profile at the 2026 American Glaucoma Society Annual Meeting Nicox announces positive NCX 470 Phase 3 data on intraocular pressure lowering efficacy at 2026 American Glaucoma Society Annual Meeting Nicox NCX 470 Phase 3 Data Intraocular Pressure Glaucoma Society
BRIEF published on 02/16/2026 at 07:35, 2 months 7 days ago Nicox is preparing an NDA submission for NCX 470 following a positive FDA opinion FDA Glaucoma NDA Nicox NCX 470
BRIEF published on 02/16/2026 at 07:35, 2 months 7 days ago Nicox Receives Positive Feedback from FDA for NCX 470 NDA FDA Nicox Glaucoma Treatment NCX 470 NDA Submission
PRESS RELEASE published on 02/16/2026 at 07:30, 2 months 7 days ago Nicox Announces Positive Feedback from pre-NDA Meeting with U.S. FDA for NCX 470 Nicox receives positive feedback from pre-NDA meeting with U.S. FDA for NCX 470, on track for NDA submission in summer 2026. NCX 470 lowers intraocular pressure in glaucoma patients FDA Nicox NCX 470 Intraocular Pressure Pre-NDA
BRIEF published on 02/12/2026 at 07:35, 2 months 11 days ago Nicox maintains its PEA-PME status for 2026 PEA-PME Euronext Growth Paris Investment Ophthalmology Nicox
BRIEF published on 02/10/2026 at 07:35, 2 months 13 days ago Nicox to Present Key Data at AGS Annual Meeting 2026 Clinical Trials Glaucoma Nicox NCX 470 AGS 2026
Published on 04/23/2026 at 18:00, 3 hours 33 minutes ago Gold Port Renews Groete Project Mining Permit; Advances Camp Reconstruction
Published on 04/23/2026 at 16:20, 5 hours 13 minutes ago CORRECTION FROM SOURCE: Avino Announces Q1 2026 Production Results
Published on 04/23/2026 at 15:00, 6 hours 33 minutes ago Critical Elements Announces the Results from The Annual Meeting of Shareholders
Published on 04/23/2026 at 14:30, 7 hours 3 minutes ago Klondike Gold Engages Fundamental Research Corp. for Analyst Coverage
Published on 04/23/2026 at 14:30, 7 hours 3 minutes ago Hillcrest Energy Technologies Finalizes A-Sample Design of ZVS PCS1000 Sidecar Power Unit for Next-Generation AI Data Centers
Published on 04/23/2026 at 18:30, 3 hours 3 minutes ago The Annual General Meeting approves all proposals
Published on 04/23/2026 at 18:30, 3 hours 3 minutes ago Readcrest Capital postpones the publication of its audited consolidated financial statements until mid-May 2026 – Sale of the UK nursing home business requires an adjusted presentation
Published on 04/23/2026 at 18:00, 3 hours 33 minutes ago Oxford Royale Academy Partners with MIT to Bring AI Education to Summer School Students
Published on 04/23/2026 at 18:00, 3 hours 33 minutes ago Sales data for the first quarter of 2026: FORVIA HELLA starts the new fiscal year with solid sales performance
Published on 04/23/2026 at 17:45, 3 hours 48 minutes ago Linedata Services: Q1 2026 revenue: €40.2m (-8.5%)
Published on 04/23/2026 at 19:27, 2 hours 6 minutes ago Annual Shareholders' Meeting 2026 - Conditions of availability of the preparatory documents
Published on 04/23/2026 at 18:18, 3 hours 15 minutes ago Aéroports de Paris SA - Sale by Groupe ADP of securities representing 3.4% with option to sell an additional 3.9% of GAL's equity share capital to GMR Group
Published on 04/23/2026 at 18:00, 3 hours 33 minutes ago 2025 Full-Year Results: Strong Top-Line Rebound (+26%)
Published on 04/23/2026 at 17:50, 3 hours 43 minutes ago Cegedim: Like-for-like revenues fell 0.8% in the first quarter of 2026
